(Q30870747)

English

Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

based on heuristic

inferred from title

Kathleen A. Cronin

9

object named as

Kathleen A Cronin

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Nadia Howlader

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Vivien W Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Lynn A G Ries

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Michelle M Loch

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Richard Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Carol DeSantis

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Chun Chieh Lin

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Jennifer Ruhl

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

language of work or name

0 references

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

120 Suppl 23

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

3771-3780

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Breast cancer statistics, 2011.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Racial and ethnic disparities in the receipt of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Incidence of breast cancer in the United States: current and future trends.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Breast cancer incidence rates in U.S. women are no longer declining

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Age-specific incidence of breast cancer subtypes: understanding the black-white crossover

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Occurrence of breast cancer subtypes in adolescent and young adult women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29059

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.29059

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30870747&oldid=2136690821"